enGene Therapeutics ENGN Growth Metrics (2023-2026)

NASDAQ ENGN
$1.77 -0.08 (-4.32%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Growth Ratios
Enterprise Value Growth (1y) (Quarter) -298.95%-192.35%-149.65%17.91%21.64%18.71%-29.06%-18.89%
Enterprise Value Growth (3y) (Quarter) -111.65%
Enterprise Value (QoQ) (Quarter) -5.06%-209.19%2.69%7.51%10.29%-1.67%7.12%4.05%-42.44%6.34%
Interest Coverage Ratio Growth (1y) (Quarter) -355.37%89.56%81.33%-102.12%-85.28%-1,342.63%-796.49%74.76%-28.07%51.48%
Interest Coverage Ratio Growth (3y) (Quarter) -121.07%9.91%
Interest Coverage Ratio (QoQ) (Quarter) -2.07%-7.66%120,597.47%-100.34%97.66%-92.42%-13,558.54%69.89%81.77%-19.58%-284.52%-52.80%93.09%
Return on Assets Growth (1y) (Quarter) 1.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 1.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 1,130.00-878.00-2138.00-3841.00-2280.00-1002.00
Return on Capital Employed (QoQ) (Quarter) 1,339.00374.00-117.00-465.00-669.00-887.00-1820.001,096.00608.00